Iron Deficiency Anemia Across Specialties: Optimizing Patient Outcomes through Collaborative Care : Episode 15
Treatment-Emergent Hypophosphatemia Following Administration of Intravenous Iron
The panel discusses the mechanism of treatment-emergent hypophosphatemia that occurs following the administration of certain intravenous iron formulations.
EP: 1.Introduction and Overview of the Physiological Role of Iron Metabolism
EP: 2.Defining Iron Deficiency
EP: 3.Common Causes of Iron Deficiency
EP: 4.Confirming Iron Deficiency Diagnosis
EP: 5.The Clinical Role of Intravenous Iron
EP: 6.Unmet Need for Addressing the Use of IV Iron
EP: 7.Real-World Applications of Intravenous Iron
EP: 8.Overview of Iron Formulations
EP: 9.Generic Formulations of Iron
EP: 10.Dose Timing with Intravenous Iron
EP: 11.Safety of Intravenous Iron
EP: 12.Infusion Reactions to Intravenous Iron
EP: 13.How to Manage Infusion Reactions with Intravenous Iron
EP: 14.Practical Tools for the Administration of Intravenous Iron
Now Viewing
EP: 15.Treatment-Emergent Hypophosphatemia Following Administration of Intravenous Iron
EP: 16.Collaboration and Communication Across the Healthcare Team
Video content above is prompted by the following:
- Treatment-emergent hypophosphatemia is now widely recognized as a phenomenon that can occur following administration of certain IV iron formulations and within the first 2 weeks after administration. Can you discuss the mechanism of treatment-emergent hypophosphatemia?
Recent Videos
Related Content
